Giovanni Brandi Selected Research

Giovanni Brandi Research Topics

Disease

62	Neoplasms (Cancer) 05/2024 - 06/2009
39	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2010
34	Cholangiocarcinoma 05/2024 - 07/2010
30	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024 - 12/2015
14	Neoplasm Metastasis (Metastasis) 05/2024 - 10/2011
10	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2008
7	Fibrosis (Cirrhosis) 04/2024 - 12/2011
6	Carcinogenesis 02/2024 - 08/2013
6	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 08/2008
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 01/2014
4	Liver Neoplasms (Liver Cancer) 01/2022 - 12/2017
3	Malignant Mesothelioma 06/2023 - 11/2020
3	Drug-Related Side Effects and Adverse Reactions 04/2023 - 03/2014
3	Mesothelioma 01/2023 - 11/2020
3	Microsatellite Instability 05/2022 - 02/2021
3	Fatigue 07/2021 - 02/2020
3	Adenocarcinoma 12/2020 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 03/2019 - 10/2008
2	Carcinoma (Carcinomatosis) 04/2024 - 02/2024
2	Margins of Excision 01/2023 - 04/2019
2	Adenocarcinoma of Lung 07/2022 - 06/2019
2	Inflammation (Inflammations) 06/2022 - 08/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 03/2022 - 04/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 12/2018
2	Klatskin Tumor 02/2021 - 06/2013
2	Erythema elevatum diutinum 01/2021 - 10/2013
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021 - 01/2021
2	Rare Diseases (Rare Disease) 11/2020 - 06/2015
2	Hypertension (High Blood Pressure) 08/2020 - 01/2019
2	Neutropenia 03/2020 - 02/2020
2	Exanthema (Rash) 03/2020 - 03/2014
2	Thrombocytopenia (Thrombopenia) 03/2020 - 02/2020
2	Nausea 02/2020 - 04/2015
2	Disease Progression 03/2019 - 03/2018
2	Liver Diseases (Liver Disease) 01/2019 - 02/2017
2	Jaundice (Icterus) 03/2016 - 04/2015
2	Hemangiosarcoma (Angiosarcoma) 07/2015 - 01/2014
2	Rectal Neoplasms (Rectal Cancer) 01/2011 - 06/2009
1	Precancerous Conditions 04/2024
1	Triple Negative Breast Neoplasms 06/2022
1	Turcot syndrome 05/2022

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 04/2023 - 06/2020
12	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2015
11	Sorafenib (BAY 43-9006)FDA Link 02/2024 - 03/2013
9	Gemcitabine FDA Link 05/2024 - 05/2010
9	AsbestosIBA 04/2024 - 05/2013
8	Capecitabine (Xeloda)FDA Link 05/2021 - 06/2009
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 08/2008
6	RamucirumabIBA 01/2021 - 02/2017
5	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2019
4	PlatinumIBA 12/2020 - 12/2015
3	pemigatinibIBA 02/2024 - 01/2021
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2024 - 06/2020
3	Bevacizumab (Avastin)FDA Link 04/2022 - 10/2013
3	atezolizumabIBA 04/2022 - 01/2021
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 02/2006
3	6-propylchromone-2-carboxylic acid (PCCA)IBA 02/2021 - 01/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2020 - 06/2020
3	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 11/2015
3	Tyrosine Kinase InhibitorsIBA 03/2018 - 10/2012
2	AlbuminsIBA 05/2024 - 04/2021
2	durvalumabIBA 05/2024 - 04/2021
2	LigandsIBA 05/2024 - 03/2018
2	futibatinibIBA 02/2024 - 04/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 07/2017
2	Transaminases (Aminotransferases)IBA 07/2021 - 04/2015
2	cabozantinibIBA 07/2021 - 02/2019
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 06/2020
2	olaparibIBA 12/2020 - 02/2020
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 03/2018
2	ErbB Receptors (EGF Receptor)IBA 03/2020 - 01/2012
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2019
2	ParaffinIBA 08/2019 - 11/2015
2	Fetal Proteins (Fetoprotein)IBA 01/2019 - 02/2017
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2018 - 09/2014
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2017 - 09/2014
2	Docetaxel (Taxotere)FDA Link 07/2015 - 10/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2012
2	Gabexate (Foy)IBA 01/2014 - 01/2012
1	Messenger RNA (mRNA)IBA 05/2024
1	CC 83IBA 04/2024
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2024
1	erdafitinibIBA 02/2024
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	lenvatinibIBA 04/2022

Therapy/Procedure

47	Therapeutics 02/2024 - 11/2005
44	Drug Therapy (Chemotherapy) 05/2024 - 06/2009
13	Immunotherapy 04/2023 - 07/2017
8	Radiotherapy 01/2022 - 07/2015
5	Radiofrequency Ablation 01/2022 - 01/2020
5	Adjuvant Chemotherapy 01/2018 - 10/2011
4	Hepatectomy 01/2021 - 10/2011
3	Neoadjuvant Therapy 04/2024 - 01/2011
3	Precision Medicine 11/2022 - 06/2020
3	Liver Transplantation 01/2021 - 12/2017
2	Combined Modality Therapy 10/2012 - 07/2010
2	Chemoradiotherapy 03/2011 - 01/2011
1	Adjuvant Chemoradiotherapy 01/2023